NL-OMON34665撤回不适用
Application of mesenchymal stem cells in patients with end-stage renal disease - MiSOT-2
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Kidney transplantation candidate with a willing donor
- •Pre-emptive (not yet on dialysis)
- •Glomerular filtration rate is between 15 and 25
- •Female subjects must be non-pregnant and non-breast-feeding
排除标准
- •Subject is HIV1, HIV2, Hepatitis B, Hepatitis C or HTLV positive
- •Subject has active infection or abscess
- •Subject has evidence or prior history of active malignancy
- •Subject previously received an organ transplant
- •Subject uses immunosuppressive medication
研究者
相似试验
进行中（未招募）
1 期
Clinical research using the mesenchymal stem cells from autologous fat tissue of Alzheimer dementiaJPRN-jRCTb050190035OOYAMA TAKAYUKI3
招募中
1 期
Cell therapy with use of mesenchymal stem cells in infertile women with Thin EndometriumIRCT20230222057500N1Tehran University of Medical Sciences10
已完成
不适用
Efficacy of mesenchymal stem cells for treatment of refractory acute GVHD after stem cell transplantatiorefractoty acute GVHD after stem cell transplantationJPRN-C000000423Jichi Medical University, Department of Medicine, Division of Hematology5
进行中（未招募）
不适用
Application of Mesenchymal Stem Cells and full of plasma in the management of the burn wound in patients with large burn injury - Stem CellsEUCTR2012-001596-36-ESMIGUEL CASARES FERNÁNDEZ-ALVÉS
进行中（未招募）
不适用
Mesenchymal stem cell based therapy for the treatment of osteogenesis imperfectaOsteogenesis imperfecta (OI) is a rare genetic disorder with increased bone fragility of varying severity. In the majority of patients the disease is caused by mutations in collagen type I. Severe OI is characterized by osteopenia, frequent fractures, progressive deformity, short stature, loss of mobility, chronic pain and can lead to premature death. At present a cure does not exist.EUCTR2012-002553-38-ESItziar Astigarraga Aguirre